Diane Hagerty

Diane Hagerty is a seasoned professional in the field of quality and compliance within the pharmaceutical and biotechnology sectors. Currently serving as the Chief Quality Officer at Kardigan, Diane has a diverse background as a self-employed Pharma/Biotech Quality Executive. Previously, Diane held the position of Senior Vice President and Head of GxP Quality & Compliance at Allogene Therapeutics and served as Vice President for the same area at MyoKardia, which was acquired by Bristol-Myers Squibb in November 2020. Additionally, Diane was the Senior Vice President of Quality, Compliance, and Operational Excellence at Dermira, Inc., prior to its acquisition by Eli Lilly in February 2020.